GAO Report Casts Shade On Sunscreen Ingredients' Chances With FDA

GAO report requested by leadership of House and Senate committees with oversight of FDA adds evidence behind an argument that the agency's monograph process for sunscreen and other OTC ingredients should be changed substantially to facilitate making more pharmaceutical remedies available nonprescription.

FDA's new drug application process won't attract sunscreen ingredient proposals even though the other option, the OTC monograph system, currently is untenable, say drug and personal care product industry stakeholders in a Government Accountability Office report.

The GAO report submitted to the leadership of the House and Senate committees with oversight of FDA (see box below)...